期刊文献+
共找到8篇文章
< 1 >
每页显示 20 50 100
克拉玛依地区脂肪肝发病情况调查
1
作者 孙安祥 焦新亮 +4 位作者 刘秋梅 陈秀玲 蒋梅香 马娉 姚海燕 《中国误诊学杂志》 CAS 2003年第7期1112-1113,共2页
关键词 脂肪肝/流行病学 脂肪组织/代谢 流行病学研究
下载PDF
二甲双胍对2型糖尿病大鼠内脏脂肪组织visfatin的作用和机制研究 被引量:4
2
作者 李健 王怀国 +2 位作者 王坤 王文汇 黄秉统 《中国医师杂志》 CAS 2015年第10期1528-1531,共4页
目的 探讨二甲双胍对2型糖尿病大鼠血清及内脏脂肪组织中visfatin表达水平的影响.方法 40只雄性Wistar大鼠按随机数字表法分为正常对照组(NC)和糖尿病组,用高糖高脂饮食加小剂量链脲佐菌素建立2型糖尿病大鼠模型,成模大鼠按随机数字... 目的 探讨二甲双胍对2型糖尿病大鼠血清及内脏脂肪组织中visfatin表达水平的影响.方法 40只雄性Wistar大鼠按随机数字表法分为正常对照组(NC)和糖尿病组,用高糖高脂饮食加小剂量链脲佐菌素建立2型糖尿病大鼠模型,成模大鼠按随机数字表法分为糖尿病对照组(DC)、二甲双胍治疗组(MET)和胰岛素治疗组(INS),分别给予生理盐水、二甲双胍、甘精胰岛素治疗8周,检测各组大鼠用药前后体质量、内脏脂肪含量、生化指标,计算胰岛素抵抗指数(HOMA-IR)、大鼠肥胖评定指数(Lee index),测定血清visfatin水平,实时定量PCR法检测内脏脂肪组织visfatin mRNA的水平.结果 与DC组比较,INS组血清visfatin及内脏脂肪组织visfatin mRNA水平未显著下降(P >0.05);MET组血清visfatin及内脏脂肪组织visfatin mRNA水平显著降低(P<0.01),但仍高于NC组(P<0.05).结论 二甲双胍可降低2型糖尿病大鼠血清visfatin水平和内脏脂肪组织visfatin mRNA的表达,改善胰岛素抵抗. 展开更多
关键词 二甲双胍/药理学 糖尿病 2型/药物疗法/代谢 烟酰胺磷酸核糖基转移酶/代谢 脂肪组织/代谢
原文传递
妊娠期糖尿病患者脂肪组织中血清淀粉样蛋白A的表达和意义 被引量:2
3
作者 钟敏 戴满花 +2 位作者 刘爱玲 李毕华 黄为群 《中国医师杂志》 CAS 2015年第4期533-536,共4页
目的 探讨血清淀粉样蛋白A(SAA)在妊娠期糖尿病脂肪组织中的表达及与胰岛素抵抗和体质量指数的关系.方法 选取单胎足月剖宫产分娩的妊娠期糖尿病孕妇30例为研究组,随机选取同期住院分娩的糖耐量正常孕妇30例为对照组.根据身高、体质... 目的 探讨血清淀粉样蛋白A(SAA)在妊娠期糖尿病脂肪组织中的表达及与胰岛素抵抗和体质量指数的关系.方法 选取单胎足月剖宫产分娩的妊娠期糖尿病孕妇30例为研究组,随机选取同期住院分娩的糖耐量正常孕妇30例为对照组.根据身高、体质量计算孕前、分娩时体质量指数及孕期体质量增长值;采用氧化酶法检测空腹血糖(FBG),放射免疫法检测空腹胰岛素(FINS)水平,计算胰岛素抵抗指数(HOMA-IR);ELISA法检测孕妇血清SAA水平;RT-PCR检测内脏及皮下脂肪组织中SAA1的mRNA的表达丰度;比较两组孕妇内脏脂肪及皮下脂肪组织的SAA1 mRNA表达量,分析其与血清的SAA、HOMA-IR及体质量指数等各项指标的关系.结果 妊娠糖尿病(GDM)组的内脏及皮下脂肪组织SAA1mRNA的表达丰度(0.447±0.069,0.291±0.067)高于对照组(0.194±0.070,0.231±0.068,P<0.01),血清SAA水平[(21.038±6.648)mg/L]及HOMA-IR(4.168±2.416)高于对照组[(14.384±12.770) mg/L,2.045±1.008,P<0.05];60例孕妇内脏及皮下脂肪组织SAA1 mRNA表达丰度与血清SAA水平呈正相关(r=0.353,0.342,P<0.01);内脏脂肪组织SAA1 mRNA表达丰度与孕前及分娩时体质量指数、孕期体质量增长及HOMA-IR呈正相关(r=0.543,0.644,0.340,0.473,P<0.01),皮下脂肪组织SAA1mRNA与孕前、分娩时体质量指数及HOMA-IR呈正相关(r=0.788,0.693,0.504,P<0.01),而与孕期体质量增长无相关(r=0.013,P>0.05).结论 SAA1 mRNA在GDM患者皮下及内脏脂肪组织表达上调,与体质量指数及胰岛素抵抗密切相关,可能通过增加胰岛素抵抗参与GDM的形成,可作为GDM的一种新的监测因子. 展开更多
关键词 糖尿病 妊娠/代谢 血清淀粉样蛋白A/代谢 脂肪组织/代谢 胰岛素抗药性 体质量
原文传递
人脂联素基因真核表达载体的构建及表达
4
作者 丁振兴 王佑民 刘莉 《安徽医科大学学报》 CAS 北大核心 2006年第5期525-527,共3页
目的克隆人脂联素(hAPM)基因及构建真核表达重组体PGEX-4T-1/hAPMcDNA,诱导表达谷胱甘肽巯基转移酶-hAPM(GST-hAPM)融合蛋白。方法应用RT-PCR法从中国汉族人大网膜脂肪垫总RNA中扩增出APMcDNA全长基因,并在基因上下游分别克隆上EcoR1、S... 目的克隆人脂联素(hAPM)基因及构建真核表达重组体PGEX-4T-1/hAPMcDNA,诱导表达谷胱甘肽巯基转移酶-hAPM(GST-hAPM)融合蛋白。方法应用RT-PCR法从中国汉族人大网膜脂肪垫总RNA中扩增出APMcDNA全长基因,并在基因上下游分别克隆上EcoR1、Sal1两个酶切位点,将其定向导入PGEX-4T-1多克隆位点,构建PGEX-4T-1/hAPM融合表达载体,转化大肠杆菌BL21(DE3)后进行诱导表达。结果从脂肪组织总RNA中扩增得到760bp片段APM基因,经双酶切鉴定及测序分析,证明hAPMcD-NA已克隆到PGEX-4T-1载体中。免疫印迹证实,诱导表达的融合蛋白可被多克隆抗体Acrp30(N-20)-R识别。结论成功诱导表达出融合蛋白GST-hAPM,为进一步获得大量可供实验研究和临床应用的重组hAPM创造条件。 展开更多
关键词 真核细胞 DNA 重组 脂肪组织/代谢
下载PDF
ATF4 regulates lipid metabolism and thermogenesis 被引量:16
5
作者 Chunxia Wang Zhiying Huang Ying Du Ying Cheng Shanghai Chen Feifan Guo 《Cell Research》 SCIE CAS CSCD 2010年第2期174-184,共11页
Activating transcription factor 4 (ATF4) has been shown to play key roles in many physiological processes. There are no reports, however, demonstrating a direct link between ATF4 and lipid metabolism. We noticed tha... Activating transcription factor 4 (ATF4) has been shown to play key roles in many physiological processes. There are no reports, however, demonstrating a direct link between ATF4 and lipid metabolism. We noticed that Atf4- deficient mice are lean, suggesting a possible role for ATF4 in regulating lipid metabolism. The goal of our current study is to investigate the involvement of ATF4 in lipid metabolism and elucidate the underlying mechanisms. Studies using Atf4-deficient mice revealed increased energy expenditure, as measured by oxygen consumption. These mice also showed increases in lipolysis, expression of uncoupling protein 2 (UCP2) and p-oxidation genes and decreases in expression of lipogenic genes in white adipose tissue (WAT), suggesting increased utilization and decreased synthesis of fatty acids, respectively. Expression of UCP1, 2 and 3 was also increased in brown adipose tissue (BAT), suggesting increased thermogenesis. The effect of ATF4 deletion on expression of UCPs in BAT suggests that increased thermogenesis may underlie increased energy expenditure. Thus, our study identifies a possible new function for ATF4 in regulating lipid metabolism and thermogenesis. 展开更多
关键词 ATF4 lipid metabolism THERMOGENESIS WAT BAT
下载PDF
Liver histology according to the presence of metabolic syndrome in nonalcoholic fatty liver disease cases 被引量:12
6
作者 Hüseyin Saadettin Uslusoy Selim Giray Nak +1 位作者 Macit Gülten Zeynep Blylkll 《World Journal of Gastroenterology》 SCIE CAS CSCD 2009年第9期1093-1098,共6页
AIM:To investigate the histologic features of the liver in nonalcoholic fatty liver disease (NAFLD) cases according to the presence of metabolic syndrome or its individual components. METHODS:We enrolled 81 patients (... AIM:To investigate the histologic features of the liver in nonalcoholic fatty liver disease (NAFLD) cases according to the presence of metabolic syndrome or its individual components. METHODS:We enrolled 81 patients (40 male,41 fe-male) who were diagnosed with fatty liver by ultraso-nographic scan and fulfi lled the inclusion criteria. First anamnesis,anthropometric,clinical,laboratory and imaging features of all participants were recorded and then liver biopsy was performed after gaining consent from patients. Diagnosis of metabolic syndrome was dependent on patients having 3 or more out of 5 risk criteria defined by the WHO. Biopsy specimens were assessed according to Brunt et al's classification. RESULTS:Sixty-nine of the 81 patients had nonalco-holic steatohepatitis (NASH),11 had simple fatty liver and 1 had cirrhosis according to histologic evaluation. Comparisons were made between two groups of NASH patients,those with and without metabolic syndrome. We did not detect statistically significant differences in liver histology between NASH patients with and wit-hout metabolic syndrome. CONCLUSION:NASH can progress without metabolic risk factors or the presence of metabolic syndrome. 展开更多
关键词 Liver histology Fatty liver Nonalcoholic steatohepatitis Metabolic risk factors Metabolic syndrome
下载PDF
Usefulness of the epicardial fat tissue thickness as a diagnostic criterion for geriatric patients with metabolic syndrome 被引量:1
7
作者 Bema Kaya Bedri Caner Kaya +7 位作者 Emel Yigit Karakas Sadettin Selcuk Baysal Dursun Cadirci Emre Erkus Ibrahim Halil Altiparmak Emin Savik Hatice Sezen Tttrgay Ulas 《Journal of Geriatric Cardiology》 SCIE CAS CSCD 2015年第4期373-377,共5页
Objective To evaluate the epicardial fat tissue thickness (EFTT) as a diagnostic criterion for geriatric patients with metabolic syn- drome (MetS). Methods Sixty geriatric patients over 65 years of age were recrui... Objective To evaluate the epicardial fat tissue thickness (EFTT) as a diagnostic criterion for geriatric patients with metabolic syn- drome (MetS). Methods Sixty geriatric patients over 65 years of age were recruited for the study. Patients were divided into two groups: Group 1 (n = 30) consisted of patients with MetS; Group 2 (n = 30) consisted of patients without MetS. Echocardiography was used to measure EFTT in all patients, and blood samples were analyzed for biochemical parameters. Results Compared to Group 2, EFTT levels of Group 1 were statistically higher (P 〈 0.05). In a binary logistic regression analysis, EFTT levels served as the independent factor for meta- bolic syndrome 03 = 17.35, SE = 4.93, Wald = 12.36, P 〈 0.001). Receivers operating characteristic Curve (ROC-curve) analysis revealed that EFTT predicted MetS with 96.7% sensitivity and 86.7% specificity above the level of 7.3 mm [area under the curve = 0.969; 95% con- fidence interval (CI): 0.928-1.00]. Conclusions The present study demonstrated that serum EFTT levels were higher in geriatric patients with MetS and can therefore be used as a diagnostic criterion for MetS. 展开更多
关键词 Epieardial fat tissue thickness GERIATRICS Metabolic syndrome
下载PDF
The relation between epicardial fat thickness and metabolic syndrome
8
作者 Sevket Balta Cengiz Ozturk +3 位作者 Mustafa Aparci Mustafa Demir Ali Osman Yildirim Turgay Celik 《Journal of Geriatric Cardiology》 SCIE CAS CSCD 2016年第4期369-370,共2页
To the editor We read the article Usefulness of the epicardial fat tissue thickness as a diagnostic criterion for geriatric patients with metabolic syndrome by Kaya, et al. The authors aimed to evaluate the epicardial... To the editor We read the article Usefulness of the epicardial fat tissue thickness as a diagnostic criterion for geriatric patients with metabolic syndrome by Kaya, et al. The authors aimed to evaluate the epicardial fat tissue thickness (EFT) as a diagnostic criterion for geriatric patients with metabolic syndrome (MetS). They concluded that EFT levels were higher in geriatric patients with MetS and can therefore be used as a diagnostic criterion for MetS. 展开更多
关键词 ATHEROSCLEROSIS Epicardial fat thickness Metabolic syndrome
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部